Products
Online Inquiry
Tricin
Cat. No.:
0225LY-1269
Appearance:
Solid
Purity:
≥98%
Identity:
Confirmed by NMR, and LC-MS.
Size:
Add to basket
Product Overview
Description:
Tricin prevents human cytomegalovirus replication by blocking CDK9 and restricts C6 glioma cell invasion and growth by upregulating microRNA-7.
Synonym:
520-32-1; 5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4H-chromen-4-one; 5,7,4'-trihydroxy-3',5'-dimethoxyflavone; 5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)chromen-4-one; 3',5'-O-dimethyltricetin; 5,7-dihydroxy-2-(4-hydroxy-3,5-dimethoxy-phenyl)chromen-4-one; Tricetin 3',5'-di-methyl ether; 5,7-Dihydroxy-2-(4-hydroxy-3,5-dimethoxyphenyl)-4H-1-benzopyran-4-one; 3',5'-di-O-methyltricetin
CAS No.:
520-32-1
Compound CID:
5281702
Formula:
C17H14O7
Formula Weight:
330.29
Specification
Relative Density:
1.483 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Tricin can be used in nutritional science to explore its potential as a natural flavonoid with anti-tumor and antioxidant activities.
Library Information
Target:
CDK
Receptor:
CDK9; CMV
Pathways:
Cell cycle/Checkpoint
Plate Number:
AOCL-17
Plate Location:
c6
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
125 mg/mL; 378.46 mM
